Clinical evaluation of vancomycin dosage in pediatric oncology patients

Pediatr Infect Dis J. 2014 Jul;33(7):731-3. doi: 10.1097/INF.0000000000000268.

Abstract

Vancomycin trough serum concentrations were below therapeutic range (8-15 mg/L) in 58% of 124 pediatric oncology patients receiving 60 mg/kg/d divided qid. Patients <6 and between 6 and 12 years had significantly lower trough concentrations than patients >12 years. A vancomycin dosage of 60 mg/kg/d is inadequate for pediatric oncology patients >12 years.

MeSH terms

  • Adolescent
  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / pharmacokinetics*
  • Anti-Bacterial Agents / pharmacology
  • Bacterial Infections / drug therapy
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Male
  • Neoplasms / complications
  • Retrospective Studies
  • Serum / chemistry
  • Vancomycin / administration & dosage*
  • Vancomycin / pharmacokinetics*
  • Vancomycin / pharmacology

Substances

  • Anti-Bacterial Agents
  • Vancomycin